• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Active smoking may increase mortality among colorectal cancer survivors

byMonica ParksandDavid Wang
February 27, 2015
in Chronic Disease, Gastroenterology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In a prospective cohort of over 2,500 patients diagnosed with non-metastatic colorectal cancer, post-diagnosis active smoking was associated with a significant increase in cancer-specific and all-cause mortality.

2. Post-diagnosis former smokers were associated with an increase in all-cause mortality, but with no increased risk of cancer-specific mortality.

Evidence Rating Level: 2 (Good)

Study Rundown: Smoking exposure has been recently attributed to an increased risk of colorectal cancer (CRC). However, the effect of smoking exposure after the diagnosis of CRC on patient survival is unclear. The purpose of this study was to evaluate the association between pre- and post-diagnosis smoking and mortality among patients with non-metastatic CRC. The study prospectively followed over 2,500 patients with localized or regional CRC for vital status and cause of death. Smoking status was determined by self-reported questionnaires. At the conclusion of this trial, post-diagnosis active smoking was associated with a higher all-cause and cancer specific mortality compared to non-smokers. Post-diagnosis former smokers were associated with an increase in all-cause mortality, but not cancer-specific mortality compared to non-smokers. The same pattern was observed in pre-diagnosis active and former smokers. The results of this study support the conclusion of a significant increase in mortality risk of smoking exposure for CRC cancer survivors. However, the study is limited by the lack of information on the treatment efficacy of these patients. Furthermore, given that smoking exposure is shown to be related to CRC of specific genetic genotypes, additional prospective trials with a focus on these correlated genotypes would clarify this association.

Click to read the study in JCO

Relevant Reading: A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish

In-Depth [prospective cohort]: This prospective trial included 2,548 patients (1,416 male and 1,132 female) with localized or regional, non-metastatic CRC from the Cancer Prevention Study II (CPS-II) nutrition cohort. All patients were free of disease at the time of enrollment. The average age at diagnosis was 73 years. The primary outcomes were all-cause and colorectal cancer-specific mortality. Smoking exposure was determined by self-reported questionnaire as never smokers, former smokers, or active smokers. Following Cox proportional hazard regression analysis, pre-diagnosis current smoking was associated with higher all-cause mortality (RR: 2.12; 95% CI: 1.65 to 2.74) and CRC–specific mortality (RR: 2.14; 95% CI: 1.50 to 3.07) compared to non-smokers, whereas former smoking was associated with only higher all-cause mortality (RR: 1.18; 95% CI: 1.02 to 1.36). Similarly, post-diagnosis current smoking was associated with higher all-cause (RR: 2.22; 95% CI: 1.58 to 3.13) and colorectal cancer–specific mortality (RR: 1.92; 95% CI: 1.15 to 3.21). Post-diagnosis former smoking was associated with only increases in all-cause mortality (RR: 1.21; 95% CI: 1.03 to 1.42), but not CRC-specific mortality (RR: 0.91; 95% CI: 0.71 to 1.18).

RELATED REPORTS

Heavy smoking is associated with visual field loss in glaucoma

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: colon cancersmoking
Previous Post

Peptides mimicking cardiac receptors combat autoimmune-mediated heart failure [PreClinical]

Next Post

Hypothyroidism prevalence correlated with fluoride in drinking water

RelatedReports

Smoking during pregnancy associated with aerobic fitness of children
Ophthalmology

Heavy smoking is associated with visual field loss in glaucoma

June 28, 2022
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

June 28, 2022
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Chronic Disease

Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

June 15, 2022
Quick Take: Intravenous patient-controlled analgesia versus thoracic epidural analgesia after open liver surgery
Chronic Disease

Segmentectomy is superior to lobectomy for patients with early-stage non-small cell lung cancer

May 3, 2022
Next Post
Hypothyroidism prevalence correlated with fluoride in drinking water

Hypothyroidism prevalence correlated with fluoride in drinking water

Family planning providers use long acting contraception more than general population

Family planning providers use long acting contraception more than general population

Obtaining consent for c-section during labor may be suboptimal

Cervical length linked with successful vaginal birth after cesarean

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma
  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.